
Mixed Pricing/Reserving role - Nearly/Newly qualif

Date Posted
11th June 2018
Reference
ZB000951PW
Sector
General Insurance
Job Type
Permanent
Location
London
Benefits
up to £85,000 + bonus and benefits
Salary
£60,000 to £85,000 Per Annum
Job Description Apply: Mixed Pricing/Reserving role - Nearly/Newly qualif
Exciting opportunity to join highly regarded Lloyd's and London Market insurer in a rare mixed pricing and reserving role. Working within the Specialty and Financial lines team, work will be varied and will include reserving, individual risk and outwards reinsurance pricing, profitability & portfolio analysis and developing rating engines and new products. Embedded with the underwriters, it is imperative prospective candidates have top notch communication skills with the ability to influence and gain buy in from the underwriters almost immediately.
You will be a senior student or nearly/newly qualified GI Actuary, ideally with London Market experience, and candidates with any combination of pricing and/or reserving experience are encouraged to apply. This is an excellent opportunity not to be missed. Please call/email Pamela Wernham on 0207 250 4718 or pamela@bolton-associates.co.uk for a confidential discussion and for more information.
|
By submitting this form you agree to our terms & conditions
&
privacy statement
Yes
No
Receive updates & notifications from Actuarial Post
Yes
No
Recruiting Now
Actuarial Post News
33 percent HNWIs actively looking to guard pensions from IHT
20 October 2025 |
State Pension age Review the £5trn heart of pension adequacy
20 October 2025 |
Transforming compliance into competitive advantage
20 October 2025 |
Beneath the surface of AI in Insurance
20 October 2025 |
Eroded pre-1997 pensions
20 October 2025 |
Transfer Values have dropped 6% since the start of the year
20 October 2025 |
Transfer Values have dropped 6% since the start of the year
20 October 2025 |
Beware the unintended consequences of a tax raising Budget
20 October 2025 |
LGPS funding hits record high before 2025 valuation outcomes
17 October 2025 |
Strong appetite for CDC ahead of regulatory milestone
17 October 2025 |